Numerous researchers have observed that IQGAP2 and IQGAP3 play antagonistic roles in gastric cancer, colorectal cancer, hepatocellular carcinoma, prostate cancer, ovarian cancer, breast cancer, and malignant lymphoma. This evidence concerns the gene IQGAP2 and breast carcinoma.